Leucid Bio’s Post

View organization page for Leucid Bio, graphic

3,758 followers

Leucid Bio and peers have published a research paper in Molecular Therapy showing a simple strategy to safely harness the armouring effects of interleukin (IL)18.   The group have tightly coupled the biological activity of IL18 to the activation state of the host CAR T-cell by the introduction of a granzyme B-dependent activation step and believe the use of this stringent system will be applicable in many experimental CAR T-cell immunotherapy approaches for cancer.   Read the full paper and learn more about how Leucid Bio is developing the next generation of CAR-T cells for hard-to-treat cancers using the links in the comments below.   Molecular Therapy is dedicated to publishing peer-reviewed research and cutting-edge reviews and commentaries promoting the sciences in #genetics, medicine and #biotechnology and is the founding journal of The American Society of Gene & Cell Therapy's official family of journals distributed by Cell Press   #GeneandCellTherapy #CARTcellTherapy 

  • No alternative text description for this image
Stefania Gobessi

Driving Biotech Excellence ➜ Transformative R&D Leadership in Oncology & Cell Therapy

5mo

what elegant and effective cell engineering! Congrats!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics